Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011837
Filing Date
2018-05-08
Accepted
2018-05-08 16:18:30
Documents
55
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20180331.htm 10-Q 1472275
2 EX-10.1 fprx-ex101_143.htm EX-10.1 70225
3 EX-10.2 fprx-ex102_144.htm EX-10.2 18188
4 EX-10.3 fprx-ex103_142.htm EX-10.3 95310
5 EX-31.1 fprx-ex311_6.htm EX-31.1 8486
6 EX-31.2 fprx-ex312_9.htm EX-31.2 8487
7 EX-32.1 fprx-ex321_11.htm EX-32.1 5333
8 EX-32.2 fprx-ex322_10.htm EX-32.2 5207
9 GRAPHIC g201805081922442812410.jpg GRAPHIC 44296
10 GRAPHIC g201805081922379822237.jpg GRAPHIC 24207
  Complete submission text file 0001564590-18-011837.txt   5950610

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT fprx-20180331.xml EX-101.INS 1362803
12 XBRL TAXONOMY EXTENSION SCHEMA fprx-20180331.xsd EX-101.SCH 36446
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20180331_cal.xml EX-101.CAL 39804
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20180331_def.xml EX-101.DEF 131766
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20180331_lab.xml EX-101.LAB 285610
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20180331_pre.xml EX-101.PRE 243342
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 18814828
SIC: 2834 Pharmaceutical Preparations